-- Roger E. Susi, 10% Owner, Director, CEO, President, Chairman, on April 20, 2026, sold 7,500 shares in Iradimed (IRMD) for $694,124. Following the Form 4 filing with the SEC, Susi has control over a total of 4,427,950 common shares of the company, with 4,427,950 controlled indirectly.
SEC Filing:
Price: $89.65, Change: $+0.47, Percent Change: +0.53%